52 results on '"Nalpas, B."'
Search Results
2. Patient motivation and 12-month treatment outcome in alcohol use disorder outpatients in France
3. P196 INVESTIGATION OF HEPATITIS C VIRUS ADAPTATION TO HOST GENETIC POLYMORPHISMS
4. 1401 GENOME-WIDE ASSOCIATION STUDY IDENTIFIES VARIANTS ASSOCIATED WITH LIVER FIBROSIS PROGRESSION IN HCV-INFECTED PATIENTS
5. Intervention study to improve smoking cessation during hospitalization
6. 405 SUPERSONIC SHEAR IMAGING IS A NEW POTENT MORPHOLOGICAL NON-INVASIVE TECHNIQUE TO ASSESS OF LIVER FIBROSIS. PART II: COMPARISON WITH FIBROSCAN
7. 406 SUPERSONIC SHEAR IMAGING IS A NEW POTENT MORPHOLOGICAL NON-INVASIVE TECHNIQUE TO ASSESS LIVER FIBROSIS. PART I: TECHNICAL FEASABILITY
8. 428 RAPID DECLINE OF LIVER STIFFNESS FOLLOWING ALCOHOL WITHDRAWAL IN HEAVY DRINKERS
9. 374 THE FIB-4 INDEX IS ACCURATE TO ASSESS LIVER FIBROSIS BEFORE AND DURING TREATMENT IN CHRONIC HEPATITIS B
10. 613 THE ANTIFIBROTIC PENTOXYPHILLINE/A-TOCOPHEROL ASSOCIATION DOES NOT LIMIT LIVER FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C – ANRS HC 10
11. Évolution de la polyconsommation de substances psycho actives chez des malades hospitalisés pour sevrage alcoolique dans un service d’addictologie entre 2001 et 2007
12. Typologie des contrevenants à l’alcoolémie routière et modalités des prises en charge
13. 617 IDENTIFICATION OF A GENETIC POLYMORPHISM CLEARLY INVOLVED IN HCV-RELATED FIBROSIS PROGRESSION
14. 821 RELATIONSHIP BETWEEN PLASMACYTOID AND MYELOID DENDRITIC CELLS AND RESPONSE TO ANTIVIRAL THERAPY
15. CA 24-Un score simple et économique appelé fib4 peut souvent remplacer d’autres méthodes invasives ou coûteuses pour évaluer la fibrose hépatique dans l’hépatite chronique C
16. CA 21-Efficacité diagnostique du fib4 au cours de l’hépatite B chronique
17. P.263 Combination of interferon and ribavirin in the treatment of dialysis patients with chronic hepatitis C
18. P.138 Evaluation of a new, non-invasive marker for fibrosis (FIB-4) in a large series of patients infected by the hepatitis C virus alone
19. P.053 Spliced hepatitis B virus RNA and liver disease
20. CA19 - Évaluation d’un nouveau marqueur non invasif de fibrose (FIB-4) dans une large série de malades infectés par le VHC
21. CA11 - Efficacité et tolérance de l’adéfovir dipivoxil au cours du traitement de l’hépatite chronique B aprés échappement à la lamivudine chez des malades transplantés rénaux et hémodialysés
22. 223 Reversibility of cirrhosis is associated with a decrease of liver-related complications
23. Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model
24. Pathological evolution of HCV-healthy carriers: A multivariate analysis
25. Diagnostic use of the Cobas HBV-PCR test in HBs Ag positive and HBV-DNA negative patients by standard hybridization
26. Factors participating in severe HCV-related liver disease in HIV/HCV co-infection
27. Virological and histopathological efficacy of anti-viral therapy in HCV-related cirrhosis
28. Long-term histopathological impact of IFN alpha in chronic hepatitis C
29. Long-term histopathological impact of IFN alpha in chronic hepatitis C
30. Long lasting suppression of disease liver activity may lead to a reversibility of cirrhosis
31. A controlled study of anti-HBV vaccine therapy in HBsAg healthy carriers
32. Marqueurs périphériques, perspectives d'avenir
33. Histological and virological evolution of long term response after ribavirin and interferon-α combination
34. Natural course of HCV infection in haemodialysed patients
35. H63D HFE gene mutation is a positive predictive factor to response to antiviral therapy in chronic hepatitis C
36. Management of hepatitis C by European hepatologists
37. Evidence for a new HBV protein encoded by a spliced RNA
38. Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa
39. Hepatocellular carcinoma in alcoholics
40. PGA score In diagnosis of alcoholic fibrosis
41. Hepatitis C viremia and anti-HCV antibodies in alcoholics
42. Dissociation of TNF and IL-1β production in chronic alcoholics without cirritosis
43. Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease
44. Relation between HCV and HBV infections in alcoholics with or without HCC
45. HIV Associated infection does not preclude severity of HBV chronic liver disease
46. HEPATITIS B VACCINATION AND ALCOHOLIC CIRRHOSIS
47. Spur cells in patients with alcoholic liver cirrhosis are associated with reduced plasma levels of apoA-II, HDL3, and LDL.
48. Cloning and sequencing of human liver cytosolic and mitochondrial aspartate aminotransferase cDNAs
49. PreS(2) antigens in recombinant vaccines against HBV enhance the human immune response. Preliminary results of a randomized trial
50. Hepatic activities and mRNAs expressions of aspartate aminotransferase isozymes during liver disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.